Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Sarcoma 1

Conditions

Thromboembolism 1Respiratory Insufficiency 1Pneumonia 1Myocardial Infarction 1Lung Neoplasms 1Arrhythmias, Cardiac 1Angina, Unstable 1Acute Coronary Syndrome 1

Interventions

Carboplatin 463Cisplatin 379Paclitaxel 313Pemetrexed 300Docetaxel 242Erlotinib Hydrochloride 240Gemcitabine 232pembrolizumab 173Radiotherapy 172Bevacizumab 169Nivolumab 130Etoposide 106Gefitinib 95Vinorelbine 84durvalumab 71atezolizumab 68Cetuximab 65Topotecan 61Drug Therapy 57Ipilimumab 55Irinotecan 54osimertinib 53Radiosurgery 52Afatinib 51Surveys and Questionnaires 38130-nm albumin-bound paclitaxel 38Albumin-Bound Paclitaxel 37Taxes 35Cyclophosphamide 35Surgical Procedures, Operative 34

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Fluoridation × Thoracic × Clear all
NCT01370278 2023-08-25

Clearance Of Mucus In Stents (COMIS)

M.D. Anderson Cancer Center

Phase NA Completed
43 enrolled
Thoracic

Angina, Unstable, Arrhythmias, Cardiac, Lung Neoplasms, Myocardial Infarction, Pneumonia, Respiratory Insufficiency, Thromboembolism, Acute Coronary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡